Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Susanne Brauninger"'
Autor:
Peter Reinhardt, Christian Seidl, Hubert Schrezenmeier, Heike Bialleck, Erhard Seifried, Arnd Schwebig, Sreekanth Gattu, Susanne Brauninger, Petra S. A. Becker, Beate Luxembourg, Halvard Bonig, Chrysanthi Tsamadou, Natalia Kaliakina, Pritibha Singh, Miriam Schulz, Joannis Mytilineos, M Wiesneth
Publikováno v:
Transfusion. 56:3055-3064
BACKGROUND Biosimilar granulocyte-colony-stimulating factors (G-CSFs) have been available in the European Union since 2008, and Sandoz' biosimilar filgrastim was approved in the United States in March 2015 for all of the reference product's indicatio
Autor:
Beate Luxembourg, K U Chow, Kristin Thorausch, Halvard Bonig, Erhard Seifried, Miriam Schulz, Susanne Brauninger
Publikováno v:
Bone Marrow Transplantation. 49:1419-1425
To minimize donor risk and maintain public support, volunteer donor stem cell donation, whether by mobilized leukapheresis or marrow aspiration, requires careful donor eligibility assessment. Many contraindications to stem cell donation exist, yet an
Autor:
Halvard Bonig, C. Varga, C. Seidl, Susanne Brauninger, B. Bomke, Torsten Tonn, H. Bialleck, Markus M. Mueller, Erhard Seifried
Publikováno v:
Vox Sanguinis. 104:46-54
Background and Objectives G-CSF-mobilized peripheral blood stem cells have long replaced marrow as the major source for allogeneic transplants. Conclusive evidence questioning the long-term safety of G-CSF for donors has not been provided, but the cu
Autor:
Halvard Bonig, Kristin Thorausch, Susanne Brauninger, Erhard Seifried, Heike Bialleck, Tom Felt
Publikováno v:
Transfusion. 52:1137-1145
BACKGROUND: Granulocyte–colony-stimulating factor–mobilized peripheral blood stem cells, collected by white blood cell apheresis, are used for more than 80% of allogeneic and most autologous hematopoietic stem cell transplantations. Optimal donor
Autor:
Klaus Dembowsky, Halvard Bonig, Christophe Escot, Eliza Wiercinska, Susanne Brauninger, Ariane Kraemer, Darja Karpova, Leon Hooftman, Garry Douglas, Belinda Stock, Eric Chevalier, Jochen Graff, Barbara Romagnoli
Publikováno v:
Blood. 126:511-511
Background: Stem cell mobilization (SCM) with G-CSF is efficient but - although overall safe - inconvenient because of the five-day injection regime and certain contraindications. Side effects, sometimes severe, are frequent. These disadvantages fuel
Autor:
Susanne, Brauninger, Heike, Bialleck, Kristin, Thorausch, Tom, Felt, Erhard, Seifried, Halvard, Bonig
Publikováno v:
Transfusion. 52(5)
Granulocyte-colony-stimulating factor-mobilized peripheral blood stem cells, collected by white blood cell apheresis, are used for more than 80% of allogeneic and most autologous hematopoietic stem cell transplantations. Optimal donor and recipient o
Autor:
Peter, Reinhardt, Susanne, Brauninger, Heike, Bialleck, Kristin, Thorausch, Richard, Smith, Hubert, Schrezenmeier, Erhard, Seifried, Markus, Wiesneth, Halvard, Bonig
Publikováno v:
Transfusion. 51(6)
Cryopreserved hematopoietic progenitor cells collected by apheresis from granulocyte-colony-stimulating factor with or without chemotherapy-mobilized patients have become the preferred type of autograft to support treatment of diseases amenable to hi
Publikováno v:
Transfusion. 51:1594-1595
Autor:
Leon Hooftman, Halvard Bonig, Klaus Dembowski, Christopher Escot, Darja Karpova, Hans Martin, Belinda Stock, Jochen Graff, Barbara Romagnoli, Garry Douglas, Achim Wach, Eric Chevalier, Susanne Brauninger, Ariane Krämer, Eliza Wiercinska
Publikováno v:
Journal of Translational Medicine
Background Certain disadvantages of the standard hematopoietic stem and progenitor cell (HSPC) mobilizing agent G-CSF fuel the quest for alternatives. We herein report results of a Phase I dose escalation trial comparing mobilization with a peptidic